Pharma Manufacturing SSI - Oct 26th, 2022
 
 
Pharma Manufacturing SSI | View online
 
October 26, 2022
Sponsored by Thermo Gibco
Sponsored

To streamline the transition to commercial production, several factors need to be considered prior to regulatory approval. Raw material analysis, establishing secondary supply chains, and building supplier relationships are key measures that could improve production efficiency and consistency. Learn more about post-approval planning in the article.

Sponsored

Developing a cell culture medium with a formulation that is both scalable and optimized for your process is essential for success. During development, a key choice is whether to use animal-origin (AO) or animal origin-free (AOF) components. Read the infographic to learn about the difference and the roles of other production media components.

Sponsored

Raw materials used in cell culture media can impact on the safety, quality, and activity of your product. Consequently, limiting variations in the chemistry and the presence of impurities in these materials are vital to maximize consistency. Read the article to find the optimal solutions for your process.

Sponsored

Backed by 60 years of bioprocessing knowledge and innovation, we are dedicated to supporting your biopharmaceutical journey by providing state-of-the-art Gibco products and trusted technical support services. Read how we are continuing our commitment to providing a dependable supply of innovative cell culture solutions.